Qube Research & Technologies LTD Optimize Rx Corp Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
A detailed history of Qube Research & Technologies LTD transactions in Optimize Rx Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 8,251 shares of OPRX stock, worth $82,510. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,251Holding current value
$82,510% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding OPRX
# of Institutions
101Shares Held
12.9MCall Options Held
18.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN1.74MShares$17.4 Million1.65% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL1.57MShares$15.7 Million4.84% of portfolio
-
Black Rock Inc. New York, NY1.09MShares$10.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$10.3 Million0.0% of portfolio
-
Awm Investment Company, Inc. New York, NY853KShares$8.53 Million1.54% of portfolio
About OptimizeRx Corp
- Ticker OPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 18,023,100
- Market Cap $180M
- Description
- OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...